ARCA biopharma, Inc.

Rentabilité sur six mois: 0%
Rendement en dividendes: 66.25%
Secteur: Healthcare

2.4 $

0 $ 0%
2.4 $
4.16 $

paper.min_max_per_year

Calendrier des promotions ARCA biopharma, Inc.

À propos de l'entreprise ARCA biopharma, Inc.

ARCA biopharma, Inc., a clinical development stage biopharmaceutical company, engages in the development and commercialization of genetically targeted therapies for cardiovascular diseases. Its lead product candidate is Gencaro, a pharmacogenetically-targeted beta-adrenergic receptor antagonist that has completed Phase IIb trial for the treatment of atrial fibrillation in patients with chronic heart failure. It is also developing Recombinant Nematode Anticoagulant Protein c2 (rNAPc2) (AB201), a protein therapeutic that is in Phase IIb clinical trial for the treatment for COVID-19. ARCA biopharma, Inc. has a collaboration agreement with LabCorp to develop genetic test for GENETIC-AF clinical trial. The company was founded in 2004 and is headquartered in Westminster, Colorado.

Paramètres de base

IPO date
1997-08-08
ISIN
US00211Y5069
Industry
Biotechnology
Sector
Health Care
Валюта
usd
Валюта отчета
usd
Див.доход ао
66.25
Дивиденд ао
20.67
Сайт

Grade

Sous-estimation
Nom Signification Grade
P/S 0 0
P/BV 0.6659 10
P/E 0 0
Efficacité
Nom Signification Grade
ROA -14.1 0
ROE -14.42 0
ROIC 0 0
Dividendes
Nom Signification Grade
Rendement en dividendes 66.25 10
DSI 1 10
Croissance moyenne du dividende 99.38 10
Devoir
Nom Signification Grade
Debt/EBITDA -0.0384 10
Debt/Ratio 0.0074 10
Debt/Equity 0.0227 10
Impulsion de croissance
Nom Signification Grade
Rentabilité Revenue, % 7721.03 10
Rentabilité Ebitda, % 30.29 5
Rentabilité EPS, % -91.08 0

Dividendes

paper.price.prices

Prix Common.min. Common.max. Changement paper.changes_in_industry paper.changes_in_index
common.calendar.number_days.1 2.4 $ 0 $ 0 $ 0 % 0 % 0 %
common.calendar.number_days.7d 2.4 $ 0 $ 0 $ 0 % 0 % 0 %
common.calendar.number_days.30d 2.4 $ 2.4 $ 2.4 $ 0 % 0 % 0 %
common.calendar.number_days.90d 2.4 $ 2.4 $ 2.4 $ 0 % 0 % 0 %
common.calendar.number_days.180d 2.4 $ 2.4 $ 2.4 $ 0 % 0 % 0 %
common.calendar.number_days.1y 3.81 $ 2.4 $ 4.16 $ -37.01 % 0 % 0 %
common.calendar.number_days.3y 2.34 $ 1.58 $ 4.16 $ 2.56 % 0 % 0 %
common.calendar.number_days.5y 7 $ 1.58 $ 7.99 $ -65.71 % 0 % 0 %
common.calendar.number_days.10y 0.28 $ 0.28 $ 19.21 $ 857.14 % 0 % 0 %
common.calendar.number_days.ytd 2.4 $ 2.4 $ 2.4 $ 0 % 0 % 0 %

Principaux propriétaires

Entreprises similaires



Gestion d'entreprise

Superviseur Titre d'emploi Paiement Année de naissance
Mr. Thomas A. Keuer President, COO & Principal Executive Officer 400.8k 1959 (66 années)
Mr. C. Jeffrey Dekker CPA CFO, Treasurer & Company Secretary 323.07k 1965 (60 années)

Informations sur l'entreprise

Adresse: United States, Westminster. CO, 10170 Church Ranch Way - Ouvrir dans google maps, Ouvrir les cartes yandex
Site web: https://www.arcabio.com